The International Journal Of Hematologic Oncology is a research journal that publishes research in the field of lymphoma, leukaemia, haematologic oncology, myeloma. This journal is published by the Future Medicine Ltd. The ISSN of this journal is 2045-1393.
Also, please check the following important details about international journal of hematologic oncology: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.
According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.
The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.
Journal Title: | International Journal of Hematologic Oncology |
Publisher: | Future Medicine Ltd |
P-ISSN: | 2045-1393 |
E-ISSN: | 2045-1407 |
Language: | English |
Country of Publisher: | United Kingdom |
APC: | Yes |
Processing Time (Weeks): | 13 |
Review Process: | Double anonymous peer review |
Subjects: | Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs | Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
The international journal of hematologic oncology is indexed in:
An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.
The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).
According to journal website, the publication fee of international journal of hematologic oncology is around 1415 USD.
The international journal of hematologic oncology has also Journal waiver policy (for developing countries, authors etc).
An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.
The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the international journal of hematologic oncology publishes research articles in 13 weeks on an average.
Visit to the official website of the journal/ conference to check the details about call for papers.
If your research is related to lymphoma, leukaemia, haematologic oncology, myeloma, then visit the official website of international journal of hematologic oncology and send your manuscript.
SIMILIAR JOURNALS
ADVANCES IN CANCER BIOLOGY-METASTASIS
ISSN:ADVANCES IN RADIATION ONCOLOGY
ISSN:BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY
ISSN: 1179-9889BREAST CANCER-BASIC AND CLINICAL RESEARCH
ISSN: 1178-2234CANCER RESEARCH COMMUNICATIONS
ISSN:TOP RESEARCH JOURNALS